Schizophrenia
|
0.700 |
AlteredExpression
|
disease |
LHGDN |
Neuronal NOS expression in the prefrontal cortex was significantly higher in individuals with schizophrenia, whereas no significant changes were found in sGC subunit mRNAs in people with schizophrenia or in controls.
|
15094474 |
2004 |
Schizophrenia
|
0.700 |
AlteredExpression
|
disease |
BEFREE |
Neuronal NOS expression in the prefrontal cortex was significantly higher in individuals with schizophrenia, whereas no significant changes were found in sGC subunit mRNAs in people with schizophrenia or in controls.
|
15094474 |
2004 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
Association analysis for the CA repeat polymorphism of the neuronal nitric oxide synthase (NOS1) gene and schizophrenia.
|
14623375 |
2003 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
The allele frequencies of the polymorphism in exon 29 of the NOS1 gene differed significantly between patients with schizophrenia and controls (chi(2) = 20.10, df = 1, P = 0.000007; relative risk = 1.92; 95% confidence interval = 1.44-2.55).
|
12140778 |
2002 |
Schizophrenia
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that the NOS1 gene polymorphism may confer increased susceptibility to schizophrenia.
|
12140778 |
2002 |
Schizophrenia
|
0.700 |
Biomarker
|
disease |
BEFREE |
Schizophreniform disorder, DD and PD-NOS constituted 6.4%, 2.8% and 7.5%, respectively, of all probands with a registry diagnosis of schizophrenia.
|
7676834 |
1995 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
BEFREE |
The finding recapitulates the previously reported phenotype of nitric oxide synthase 1-deficient mice, which have achalasia.
|
25479138 |
2015 |
Esophageal Achalasia
|
0.520 |
GermlineCausalMutation
|
disease |
ORPHANET |
The finding recapitulates the previously reported phenotype of nitric oxide synthase 1-deficient mice, which have achalasia.
|
25479138 |
2015 |
Esophageal Achalasia
|
0.520 |
GeneticVariation
|
disease |
BEFREE |
To assess whether some functional polymorphisms in the nNOS, iNOS, or eNOS genes are involved in susceptibility to suffer from achalasia.
|
16848803 |
2006 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms.
|
16024729 |
2005 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Cortical interneurons become activated by deafferentation and instruct the apoptosis of pyramidal neurons.
|
15381772 |
2004 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Attenuation of activity-induced increases in cerebellar blood flow in mice lacking neuronal nitric oxide synthase.
|
12623792 |
2003 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Vasculoprotective roles of neuronal nitric oxide synthase.
|
12397095 |
2002 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Lower esophageal sphincter is achalasic in nNOS(-/-) and hypotensive in W/W(v) mutant mice.
|
11438492 |
2001 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Carbon monoxide and nitric oxide as coneurotransmitters in the enteric nervous system: evidence from genomic deletion of biosynthetic enzymes.
|
10677545 |
2000 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Infarct size and nitric oxide synthase in murine myocardium.
|
10652188 |
2000 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance.
|
10905473 |
2000 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Nocturnal motor coordination deficits in neuronal nitric oxide synthase knock-out mice.
|
10077313 |
1999 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice.
|
10362674 |
1999 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Neuronal NOS provides nitrergic inhibitory neurotransmitter in mouse lower esophageal sphincter.
|
10444441 |
1999 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Absence of cerebellar long-term depression in mice lacking neuronal nitric oxide synthase.
|
10456061 |
1999 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Effects of nitric oxide synthase gene knockout on neurotransmitter release in vivo.
|
9692709 |
1998 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice.
|
8667023 |
1996 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase.
|
7522345 |
1994 |
Esophageal Achalasia
|
0.520 |
Biomarker
|
disease |
MGD |
Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS.
|
7518615 |
1994 |